Affymetrix Inc. has announced that the University of Ottawa Heart Institute (UOHI) is using the Affymetrix Genome-Wide Human SNP Array 6.0 for its whole-genome association study on coronary artery ...
Affymetrix, Inc. has announced the launch of Axiom Strawberry Genotyping Array (also called International Strawberry 90K SNP array or IStraw90), the only solution that successfully enables ...
SANTA CLARA, Calif., Oct. 19, 2006 – Affymetrix Inc. (Nasdaq: AFFX) announced today that researchers at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona have used the ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (NASDAQ:AFFX) introduces Axiom ® Transplant Genotyping Array, designed in collaboration with an international team of surgeons and scientists for ...
An understanding of the global patterns of loss of heterozygosity in a neoplasm is achieved by analysis of polymorphic markers, or allelotyping, which is essential for both identification of new tumor ...
PAM50 intrinsic subtyping and pathologic responses to neoadjuvant trastuzumab-based chemotherapy in HER2-positive breast cancer. Background: Early detection and monitoring the progress of common ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has delivered the first custom array designed for a 100,000-sample genotyping project to be performed ...
Xcel microarray is built around Affymetrix’ Human Genome U133 Plus 2.0 array. Affymetrix negotiated exclusive distribution rights to Almac Group’s Xcel™ array microarray, which has been developed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results